SEC Filing Summary: Nukkleus Inc. (NUKK)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Nukkleus Inc. on November 26, 2025. The filing discloses the pricing of the Initial Public Offering (IPO) of SC II Acquisition Corp. ("SCII"), a newly formed special purpose acquisition company (SPAC) and indirect subsidiary of Nukkleus. SC Capital II Sponsor LLC, an indirect subsidiary in which Nukkleus holds a majority interest, is acting as the sponsor for SCII.
Key Financial Metrics
The filing details the capitalization of the SCII IPO rather than Nukkleus's consolidated operating results.
- Gross Proceeds: Approximately $150,000,000 from the sale of 15,000,000 Units.
- Offering Price: $10.00 per Unit.
- Unit Composition: One Class A ordinary share and one Share Right (entitling the holder to 1/5 of one share upon business combination).
- Over-Allotment Option: Underwriters have an option to purchase up to 2,250,000 additional Units, potentially generating up to $22.5 million in additional gross proceeds.
- Sponsor Private Placement: The Sponsor will acquire 255,000 Units at $10.00 per Unit simultaneously with the IPO closing.
Note: The filing text does not provide clear values for Nukkleus Inc.'s revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
The primary material event is the formation and IPO pricing of the subsidiary SPAC, SCII. This represents a new capital-raising vehicle for the company. The IPO is expected to close on or about November 28, 2025.
Outlook, Risks, and Management Commentary
Management has announced the pricing of the IPO as a significant corporate event. The filing includes a press release as Exhibit 99.1. The text notes that the information in the press release is not deemed "filed" for purposes of Section 18 of the Exchange Act. No specific risks, contingencies, or unusual items regarding Nukkleus's core operations are detailed in this specific 8-K text, other than the standard mechanics of the SPAC transaction.
Investor Verification Checklist
- Verify the closing date of the SCII IPO (expected November 28, 2025).
- Confirm the exercise of the underwriters' over-allotment option to determine total capital raised.
- Review the full text of the press release (Exhibit 99.1) for details on the use of proceeds and the SPAC's target sector.
- Check subsequent filings for the impact of the SPAC transaction on Nukkleus's consolidated balance sheet and cash position.